7,246 participants, various community settings
4,701 (65%) tests read
809 (17%) reactors
409 eligible for treatment
84 completed treatment
Bock NN, Metzger BS, Tapia JR, Blumberg HM. American Journal of
Respiratory & Critical Care Medicine. 1999
;
159:295-300.